In-Person US FDA Meetings Returning? Agency Will Support Those Events At HQ

A workshop broadcast from White Oak was a shift from the fully virtual meetings held since the height of the COVID-19 pandemic and may be a step toward once again staging public events there.

FDA biosimilar workshop panel discussion — The audience was virtual, but many FDA speakers attended the biosimilars workshop in person. • Source: Screenshot of FDA broadcast

The scene on the screen felt familiar, even though it has been largely absent for more than two years: FDA Commissioner Robert Califf, standing at the main podium in the agency’s White Oak headquarters conference center, giving a speech to open a workshop on streamlining biosimilar development.

FDA staff and others in the room applauded after Califf’s 10-minute talk. Then a group of biosimilar experts emerged in...

In-Person US FDA Meetings Returning? Agency Will Support Those Events At HQ

More from US FDA

More from Agency Leadership